| |
| |
|
| Insider
Information: |
Kopczynski Casey C. |
| Relationship: |
Chief Scientific Officer |
| City: |
Bedminster |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aerie Pharmaceuticals Inc |
AERI |
Chief Scientific Officer |
2022-11-21 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-11-21 |
4 |
D |
$15.25 |
$4,273,721 |
D/D |
(280,244) |
0 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
19,015 |
280,244 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-08 |
4 |
D |
$7.33 |
$5,131 |
D/D |
(700) |
261,229 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-07 |
4 |
D |
$7.24 |
$5,075 |
D/D |
(701) |
261,929 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-06 |
4 |
D |
$7.05 |
$6,176 |
D/D |
(876) |
262,630 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2022-02-04 |
4 |
D |
$7.05 |
$6,789 |
D/D |
(963) |
263,506 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-23 |
4 |
D |
$15.66 |
$5,136 |
D/D |
(328) |
264,469 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-15 |
4 |
D |
$16.41 |
$11,897 |
D/D |
(725) |
264,797 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-15 |
4 |
OE |
$0.20 |
$11,888 |
D/D |
60,651 |
265,522 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-08 |
4 |
D |
$17.72 |
$11,802 |
D/D |
(666) |
204,871 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-07 |
4 |
D |
$17.68 |
$12,394 |
D/D |
(701) |
205,537 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-06 |
4 |
D |
$17.68 |
$15,488 |
D/D |
(876) |
206,238 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
207,114 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-11-11 |
4 |
AS |
$13.01 |
$295,210 |
D/D |
(22,695) |
196,114 |
0 |
% |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-11-10 |
4 |
AS |
$13.00 |
$94,965 |
D/D |
(7,305) |
218,809 |
0 |
% |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-02-24 |
4 |
D |
$20.30 |
$13,581 |
D/D |
(669) |
226,114 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-02-23 |
4 |
D |
$21.59 |
$7,082 |
D/D |
(328) |
226,783 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-02-08 |
4 |
D |
$20.49 |
$14,343 |
D/D |
(700) |
227,111 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-02-07 |
4 |
D |
$20.49 |
$14,343 |
D/D |
(700) |
227,811 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
228,511 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-12-03 |
4 |
OE |
$0.41 |
$47,385 |
D/D |
117,000 |
218,511 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-25 |
4 |
D |
$40.18 |
$21,456 |
D/D |
(534) |
101,511 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-24 |
4 |
D |
$40.04 |
$26,787 |
D/D |
(669) |
102,045 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-23 |
4 |
D |
$40.04 |
$13,133 |
D/D |
(328) |
102,714 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2019-02-08 |
4 |
D |
$40.39 |
$28,313 |
D/D |
(701) |
103,042 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
